Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02522715
Title Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Hormone-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

prostate cancer

Therapies

Cabazitaxel + Enzalutamide

Prednisone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
OHSU Knight Cancer Institute Portland Oregon 97239 United States Details
Portland VA Medical Center Portland Oregon 97239 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field